Private sector provision and financing of AIDS treatment in Africa: Current developments

Current HIV/AIDS Reports

Volumn 4, Issue 4, 2007, Pages 192-200

  Feeley, Frank ^a   Connelly, Patrick ^b   Rosen, Sydney ^b  

^a BOSTON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; EMPLOYER; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HEALTH INSURANCE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORGANIZATION AND MANAGEMENT; PREVALENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH; PRIVATE SECTOR;

EID: 38349070758     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-007-0028-3     Document Type: Article

References (29)

1. Joint United Nations Programme on HIV/AIDS Fact Sheet. http://data.unaids.org/pub/EpiReport/2006/20061121_EPI_FS_SSA_en.pdf. Accessed June 9, 2007.
2. World Health Organization Progress in Global Access of HIV Antiretroviral Therapy. http://www.who.int/hiv/fullreport_en_highres.pdf. Accessed June 9, 2007.
3. World Bank: Health Transitions, Disease Burdens, and Health Expenditure Patterns. http://siteresources.worldbank.org/INTHSD/Resources/ topics/Health-Financing/HFRChap1.pdf. Accessed June 18, 2007.
4. Preker A, Carrin G, Dror D, et al.: A Synthesis Report on the Role of Communities in Resource Mobilization and Risk Sharing. Geneva: World Health Organization Commission on Macroeconomics and Health; 2001.
5. Feeley F, Connelly P, Rosen S: Assessing the potential for insurance and other private sector financing schemes to increase access to HIV/AIDS services in sub-Saharan Africa. Boston: CIHD Project Report, July 2005. http://sph.bu.edu/images/stories/scfiles/cih/ PrivateSectorFinancingandAccesstoHIV-AIDSServicesinSub-SaharanAfrica.pdf. Accessed June 18, 2007.
6. Feeley F, Bukuluki P, Cowley P: The Role of the Private Sector in Preventing and Treating HIV/AIDS in Uganda: An Assessment of Current Activities and the Outlook for Future Action. Boston: CIHD Project Report; 2004. http://sph.bu.edu/images/stories/scfiles/cih/UgandaPrivateSectorHIVPhaseI3.30. 04.pdf. Accessed August 8, 2007.
7. Kabugo C, Bahendeka S, Mwebaze R, et al.: Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses. J Acquir Immune Defic Syndr 2006, 38:578-583.
8. Bisson M, Gaolathe T, Ndwapi N, et al.: Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector. Res Lett AIDS 2006, 20:1333-1336. Supports the need to minimize out-of-pocket cost in order to maximize adherence.
9. Rinke de Wit T, Janssens V, Oddoye E, et al.: Establishing a network of private sector providers offering HAART in Ghana [abstract MoPeE4158]. Presented at the XV International AIDS Conference. Bangkok, Thailand; July 11-16, 2004.
10. Montagu D, Elzinga G: Increasing access to affordable quality care in Africa through the private sector: Health franchising for TB and HIV/AIDS [abstract TuPeE5469]. Presented at the XV International AIDS Conference. Bangkok, Thailand; July 11-16, 2004.
11. England R: HIV Antiretroviral Therapy: Can Franchising Expand Coverage? London: DFID Health Resource Centre; 2006.
12. Yeboah K, Eghan K, Abondo C, Shields J: Franchising ART Services for improving access to treatment - private provider networks in Africa [abstract CDB1238]. Presented at the XVI International AIDS Conference. Toronto, Canada; August 13-18, 2006.
13. South African Business Coalition on HIV/AIDS: The Impact of HIV/AIDS on Selected Business Sectors in South Africa. http://www.ber.sun.ac.za/ downloads/2005/aids/HIVAIDS_Report2005.pdf. Accessed June 9, 2007.
14. Connelly P, Rosen S: Treatment for HIV/AIDS at South Africa's largest employers: myth and reality. S Afr Med J 2006, 96:128-133. Only identified article comparing treatment uptake rates between direct employer treatment and insurance-based treatment.
15. Van der Borght S, Richards S, Rinke de Wit T, et al.: A successful workplace program for VCT and HAART at Heineken, Rwanda. IJOEH 2007, 13:99-106. One of the oldest employer-based treatment programs in Africa. Includes qualitative study of employee attitudes and quantitative analysis of treatment uptake, including evidence that patients who are HIV positive are now entering treatment programs at an earlier stage of the disease.
16. Charalambous S, Grant A, Day J, et al.: Establishing a workplace antiretroviral therapy programme in South Africa. AIDS Care 2007, 19:34-41. Results reported by one of the largest on-site employer treatment programs in Africa.
17. Van der Borght S, Rinke de Wit T, Janssens V, et al.: HAART for the HIV-infected employees of large companies in Africa. Lancet 2006, 368:547-550. Argues from Heineken experience that employer-based treatment in Africa is feasible and effective.
18. Johnson L, McLeod H: Steady growth in antiretroviral treatment provision by disease management and community treatment programs. S Afr Med J 2007, 97:358-359.
19. Feeley F, DeBeer I, Rinke de Wit T, VanderGaag J: The Health Insurance Industry in Namibia: Baseline Report. Boston: CIHD Project Report; 2006. Available at http://sph.bu.edu/images/stories/scfiles/cih/ final_namibia_insurance_situation__june_2006.pdf.
20. PharmAccess Foundation. http://www.pharmaccess.org/Default.asp? Page=156. Accessed June 18, 2007.
21. Foreign Investment in Health Receives a Boost. This Day. January 25, 2007.
22. Feeley F: PSP Ethiopia Trip Report. Bethesda: Abt Associates, Inc.; 2005.
23. Burka Y, Feeley F, Forbes S: Using Employer Solidarity Funds in Ethiopia to Support HIV/AIDS Treatment. Presented at the 2006 PEPFAR HIV/AIDS Implementers' Meeting. Durban, South Africa; June 12-15, 2006.
24. Ellis J, Feeley F, Cowley P. Case study of Hima Cement in Uganda: leveraging private sector resources for community AIDS treatment. Submitted to the World Economic Forum, May 2007.
25. Pellerin C: US Company Expands Access to AIDS Drugs in South Africa. Washington, DC: US Department of State; 2005.
26. Connelly P, Rosen S: Will small and medium enterprises provide HIV/AIDS services to employees? An analysis of market demand. S Afr J Econ 2005, 73:613-626. Extensive survey showing that small and medium industries are unlikely to fund or purchase the same direct interventions as larger employers.
27. Connelly P, Rosen S: Opportunities to expand HIV/AIDS services to employees of small and medium-sized companies in Wynberg, South Africa. Boston: CIHD Project Report, April 2005. http://sph.bu.edu/images/stories/scfiles/ cih/HIVservicesforWynbergSMEsApril2005.pdf. Accessed June 18, 2007.
28. Schneider D: Cost of Funding Antiretroviral Therapy. Washington, DC: Medical Express Ltd. Actuarial Solutions; 2003.
29. Feeley F: Technical Assistance in Developing Private Sector Resources for the Treatment of HIV/AIDS in Namibia. Washington, DC: Commercial Market Strategies; 2004.